You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 6,713,090


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,713,090
Title: Apparatus and method for preparing microparticles
Abstract:Apparatus and method for preparing microparticles. An emulsion is formed by combining two phases in a static mixing assembly. The static mixing assembly preferably includes a preblending static mixer and a manifold. The emulsion flows out of the static mixing assembly into a quench liquid whereby droplets of the emulsion form microparticles. The residence time of the emulsion in the static mixing assembly is controlled to obtain a predetermined particle size distribution of the resulting microparticles.
Inventor(s): Lyons; Shawn L. (Cincinnati, OH), Wright; Steven G. (Madeira, OH)
Assignee: Alkermas Controlled Therapeutics Inc. II (Cambridge, MA)
Application Number:10/355,061
Patent Claim Types:
see list of patent claims
Use; Formulation;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 6,713,090

Introduction

When analyzing a patent, understanding its scope, claims, and the broader patent landscape is crucial for determining its value, potential applications, and any gaps or opportunities. This article will delve into the specifics of United States Patent 6,713,090, exploring its claims, scope, and the context within which it exists.

Understanding Patents and Claims

Before diving into the specifics of Patent 6,713,090, it's essential to understand the basics of patents and claims. A patent is a form of intellectual property that gives the owner the right to exclude others from making, using, selling, and importing an invention for a certain period. The claims section of a patent is the most critical part, as it defines the scope of the invention and what is protected[5].

Patent 6,713,090 Overview

To analyze Patent 6,713,090, we need to identify its key components:

Invention Description

The patent description outlines the specific embodiment of the invention, including any processes, machines, manufactures, compositions of matter, or improvements. This section must describe the invention completely and explain the best mode of carrying out the invention[5].

Claims

The claims section is where the patentee defines the scope of the patent protection. Each claim must particularly point out and distinctly claim the subject matter regarded as the invention. Multiple claims can be presented, but they must differ substantially and not be unduly multiplied[5].

Scope of Patent 6,713,090

Claims Analysis

To understand the scope of Patent 6,713,090, one must carefully analyze each claim. Here are some key points to consider:

  • Independent Claims: These claims stand alone and do not depend on other claims. They define the broadest scope of the invention.
  • Dependent Claims: These claims depend on other claims and narrow down the scope by adding additional limitations.
  • Claim Language: The language used in the claims is critical. It must be clear and distinct to avoid ambiguity and potential infringement issues.

Scope Concepts

Patent analytics tools often categorize patents by scope concepts, which are overarching themes that link claims on similar patents. This helps in filtering, searching, and analyzing large numbers of patent claims concurrently. For Patent 6,713,090, identifying these scope concepts can help in understanding its broader applicability and potential gaps in coverage[3].

Patent Landscape

Competing Patents

Understanding the patent landscape involves identifying other patents that may be similar or overlapping. This includes analyzing patents held by competitors and determining if there are any gaps or opportunities for innovation.

Patent Analytics

Tools like Claim Coverage Matrix and Claim Charts can be used to review patent coverage. These tools help in categorizing patents by claims and scope concepts, making it easier to determine if a particular scope concept is applicable to a target product or method[3].

Exclusivity and Expiration Dates

For pharmaceutical or drug-related patents, exclusivity periods and expiration dates are crucial. The Orange Book, for example, provides information on patent exclusivity and therapeutic equivalence evaluations, which can impact the patent's value and market position[4].

Case Study: Naltrexone Patent Example

While the specific details of Patent 6,713,090 are not provided here, we can use the example of Naltrexone (Patent DB00704) to illustrate how to analyze a patent's scope and claims.

  • Mechanism of Action: Naltrexone is a pure opioid antagonist, acting on mu-type, kappa-type, and delta-type opioid receptors. Understanding its mechanism of action helps in defining its scope and potential applications[1].
  • Clinical Trials and Approvals: The number of clinical trials and approvals can indicate the patent's validity and market readiness. Naltrexone has undergone numerous clinical trials across various phases, which supports its therapeutic use[1].

Key Takeaways

  • Claims Are Critical: The claims section of a patent defines its scope and protection.
  • Scope Concepts: Analyzing scope concepts helps in understanding the broader applicability of the patent.
  • Patent Landscape: Identifying competing patents and using patent analytics tools is essential for navigating the patent landscape.
  • Exclusivity and Expiration: Understanding exclusivity periods and expiration dates is vital for pharmaceutical and drug-related patents.

FAQs

What is the primary purpose of the claims section in a patent?

The primary purpose of the claims section is to define the scope of the patent protection and what is regarded as the invention.

How do scope concepts help in patent analysis?

Scope concepts help in categorizing patents by overarching themes, making it easier to filter, search, and analyze large numbers of patent claims concurrently.

What is the significance of exclusivity periods in pharmaceutical patents?

Exclusivity periods determine the time during which the patent holder has exclusive rights to market the drug, impacting its market position and value.

How can patent analytics tools assist in reviewing patent coverage?

Patent analytics tools like Claim Coverage Matrix and Claim Charts help in categorizing patents by claims and scope concepts, making it easier to determine gaps or opportunities in coverage.

What is the role of clinical trials in validating a patent?

Clinical trials provide evidence of the patent's validity and market readiness by demonstrating its safety and efficacy through various phases of testing.

Sources

  1. DrugBank: Naltrexone: Uses, Interactions, Mechanism of Action.
  2. USPTO: Patent Claims Research Dataset.
  3. SLWIP: Patent Analytics.
  4. USPTO: Orange Book Cumulative Supplement.
  5. USPTO: Applying for Patents.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 6,713,090

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 6,713,090

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 286722 ⤷  Subscribe
Austria 349201 ⤷  Subscribe
Australia 2750801 ⤷  Subscribe
Australia 3437901 ⤷  Subscribe
Australia 771497 ⤷  Subscribe
Australia 773734 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.